Clinical trials
Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 8 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 5 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Institute of Hematology and Blood Transfusion, Czech Republic | 3 |
| Bristol-Myers Squibb | 2 |
| Charite University, Berlin, Germany | 2 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| St. Anna Kinderkrebsforschung | 2 |
| Affimed GmbH | 1 |
| Ascentage Pharma Group Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 32 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Recurrence | 4 |
| Burkitt Lymphoma | 3 |
| Leukemia, Biphenotypic, Acute | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Leukemia, Myeloid, Accelerated Phase | 3 |
| Lymphoma | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 26 to 32 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.